Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | MYC | P01106 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.46 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Toluic Acid SCHEMBL28260250 | 0.91 | ALDH1A1 (0.52) | NPC1RAB9AMYCALDH1A1HPGD | |
| Toluic Acid SCHEMBL551745 | 0.89 | ALDH1A1 (0.57) | NPC1RAB9AMYCALDH1A1HPGD | |
| Biphenyl SCHEMBL8525491 | 0.87 | ALDH1A1 (0.61) | NPC1RAB9AALDH1A1HPGDKDM4E | |
| Toluic Acid SCHEMBL28867109 | 0.83 | ALDH1A1 (0.52) | NPC1RAB9AMYCALDH1A1HPGD | |
| Toluic Acid SCHEMBL29414127 | 0.82 | ALDH1A1 (0.65) | MYCALDH1A1HPGDKDM4EHSD17B10 | |
| Toluic Acid SCHEMBL6571818 | 0.82 | ALDH1A1 (0.65) | MYCALDH1A1HPGDKDM4EHSD17B10 | |
| Toluic Acid SCHEMBL4152 | 0.82 | ALDH1A1 (0.65) | MYCALDH1A1HPGDKDM4EHSD17B10 | |
| Toluic Acid SCHEMBL28037745 | 0.82 | ALDH1A1 (0.65) | MYCALDH1A1HPGDKDM4EHSD17B10 | |
| Toluic Acid SCHEMBL148201 | 0.82 | ALDH1A1 (0.65) | MYCALDH1A1HPGDKDM4EHSD17B10 | |
| Toluic Acid SCHEMBL4730975 | 0.80 | ALDH1A1 (0.62) | MYCALDH1A1HPGDKDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2308910-B1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL CO (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-8999523-B2 | Compound containing 1,3-diene structure and method for producing same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-04-07 | — | — | US | disclosed |
| US-8993124-B2 | Polymer compound comprising aryl repeating units with crosslinking pendent groups and light-emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-03-31 | — | — | US | disclosed |
| EP-2311893-B1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL CO (JP) | 2014-09-24 | — | — | EP | disclosed |
| US-20110127517-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY ,LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2311893-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | Sumitomo Chemical Company, Limited (JP) | 2011-04-20 | — | — | EP | disclosed |
| EP-2308910-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | Sumitomo Chemical Company, Limited (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-20100301310-A1 | POLYMER AND POLYMERIC LUMINESCENT ELEMENT EMPLOYING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | RER1, NAP1L1, CRY1 | NPC1 3715/4885RAB9A 3258/4885MYC 3599/4885 |
| US-20110127517-A1 | COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME | KCNMA1, KCNA1, KCNJ11 | NPC1 1190/4885RAB9A 2699/4885MYC 2169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.